tert-butyl (S)-N-{2-hydroxy-3-[4-(methoxymethoxy)phenoxy]propyl}-N-(2-{4-[(2-hydroxy-2-phenylacetyl)amino]phenyl}ethyl)carbamate | 1160619-90-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: tert-butyl (S)-N-{2-hydroxy-3-[4-(methoxymethoxy)phenoxy]propyl}-N-(2-{4-[(2-hydroxy-2-phenylacetyl)amino]phenyl}ethyl)carbamate
• 英文别名: tert-butyl N-[(2S)-2-hydroxy-3-[4-(methoxymethoxy)phenoxy]propyl]-N-[2-[4-[(2-hydroxy-2-phenylacetyl)amino]phenyl]ethyl]carbamate
• CAS: 1160619-90-8
• 化学式: C₃₂H₄₀N₂O₈
• 分子量: 580.678
• InChiKey: NXXJEXNUBGYJBK-QUWDGAPNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  42
• 可旋转键数：
  16
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  127
• 氢给体数：
  3
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  tert-butyl (S)-N-{2-hydroxy-3-[4-(methoxymethoxy)phenoxy]propyl}-N-(2-{4-[(2-hydroxy-2-phenylacetyl)amino]phenyl}ethyl)carbamate 在 盐酸 作用下， 以 甲醇 、 乙酸乙酯 为溶剂， 反应 1.0h， 以44%的产率得到(S)-4'-(2-{[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino}ethyl)-2-hydroxy-2-phenylacetanilide hydrochloride
  参考文献：
  名称：

  Discovery of novel acetanilide derivatives as potent and selective β3-adrenergic receptor agonists

  摘要：

  In the search for potent and selective human beta 3-adrenergic receptor (AR) agonists as potential drugs for the treatment of obesity and noninsulin-dependent (type II) diabetes a novel series of acetanilide-based analogues were prepared and their biological activities were evaluated at the human beta 3-, beta 2-, and beta 1-ARs. Among these compounds, 2-pyridylacetanilide (2f), pyrimidin-2-ylacetanilide (2u), and pyrazin-2-ylacetanilide (2v) derivatives exhibited potent agonistic activity at the beta 3-AR with functional selectivity over the beta 1- and beta 2-ARs. In particular, compound 2u was found to be the most potent and selective beta 3-AR agonist with an EC(50) value of 0.11 mu M and no agonistic activity for either the beta 1 - or beta 2-AR. In addition, 2f, 2u, and 2v showed significant hypoglycemic activity in a rodent diabetic model. (C) 2009 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2009.01.022
• 作为产物：
  描述：

  tert-butyl (S)-N-[2-(4-aminophenyl)ethyl]-N-{2-hydroxy-3-[4-(methoxymethoxy)phenoxy]-propyl}carbamate 、 扁桃酸 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 15.0h， 以99%的产率得到tert-butyl (S)-N-{2-hydroxy-3-[4-(methoxymethoxy)phenoxy]propyl}-N-(2-{4-[(2-hydroxy-2-phenylacetyl)amino]phenyl}ethyl)carbamate
  参考文献：
  名称：

  Discovery of novel acetanilide derivatives as potent and selective β3-adrenergic receptor agonists

  摘要：

  In the search for potent and selective human beta 3-adrenergic receptor (AR) agonists as potential drugs for the treatment of obesity and noninsulin-dependent (type II) diabetes a novel series of acetanilide-based analogues were prepared and their biological activities were evaluated at the human beta 3-, beta 2-, and beta 1-ARs. Among these compounds, 2-pyridylacetanilide (2f), pyrimidin-2-ylacetanilide (2u), and pyrazin-2-ylacetanilide (2v) derivatives exhibited potent agonistic activity at the beta 3-AR with functional selectivity over the beta 1- and beta 2-ARs. In particular, compound 2u was found to be the most potent and selective beta 3-AR agonist with an EC(50) value of 0.11 mu M and no agonistic activity for either the beta 1 - or beta 2-AR. In addition, 2f, 2u, and 2v showed significant hypoglycemic activity in a rodent diabetic model. (C) 2009 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2009.01.022

文献信息

• Discovery of novel acetanilide derivatives as potent and selective β3-adrenergic receptor agonists
  作者：Tatsuya Maruyama、Kenichi Onda、Masahiko Hayakawa、Tetsuo Matsui、Toshiyuki Takasu、Mitsuaki Ohta

  DOI：10.1016/j.ejmech.2009.01.022

  日期：2009.6

  In the search for potent and selective human beta 3-adrenergic receptor (AR) agonists as potential drugs for the treatment of obesity and noninsulin-dependent (type II) diabetes a novel series of acetanilide-based analogues were prepared and their biological activities were evaluated at the human beta 3-, beta 2-, and beta 1-ARs. Among these compounds, 2-pyridylacetanilide (2f), pyrimidin-2-ylacetanilide (2u), and pyrazin-2-ylacetanilide (2v) derivatives exhibited potent agonistic activity at the beta 3-AR with functional selectivity over the beta 1- and beta 2-ARs. In particular, compound 2u was found to be the most potent and selective beta 3-AR agonist with an EC(50) value of 0.11 mu M and no agonistic activity for either the beta 1 - or beta 2-AR. In addition, 2f, 2u, and 2v showed significant hypoglycemic activity in a rodent diabetic model. (C) 2009 Elsevier Masson SAS. All rights reserved.